Another study highlighted that exosomal LGALS9 from glioblastoma multiforme tumors could bind to the TIM3 receptor of DCs, inhibiting DC antigen presentation and suppressing CD8+ T cell activation (94). The gene discussed is CD8A; the disease is glioblastoma.